SinoMab BioScience Marge brute
Quel est le Marge brute de SinoMab BioScience?
Le Marge brute de SinoMab BioScience Limited est 78.59%
Quelle est la définition de Marge brute?
La marge brute est la différence entre le revenu et le coût des biens vendus, divisée par le revenu et exprimée en pourcentage.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Marge brute des entreprises dans Health Care secteur sur HKSE par rapport à SinoMab BioScience
Que fait SinoMab BioScience?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
Entreprises avec marge brute similaire à SinoMab BioScience
- Rua Life Sciences Plc a Marge brute de 78.54%
- Acrow Formwork and Construction Services a Marge brute de 78.56%
- Uniti a Marge brute de 78.57%
- LifeTech Scientific a Marge brute de 78.57%
- Servicenow Dl ,001 a Marge brute de 78.59%
- ServiceNow Inc a Marge brute de 78.59%
- SinoMab BioScience a Marge brute de 78.59%
- Tera Software a Marge brute de 78.59%
- i-nexus Global plc a Marge brute de 78.59%
- F-Secure Oyj a Marge brute de 78.60%
- Magellan a Marge brute de 78.61%
- Prozone Intu Properties a Marge brute de 78.63%
- Pandora AS a Marge brute de 78.63%